Comparison of Heart Rate Variability Analysis Durations and Their Relationship With Blood Pressure

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorSinop University

About this trial

This observational study aims to compare heart rate variability (HRV) parameters obtained from different analysis durations in healthy adults and to examine how these parameters relate to resting blood pressure values. HRV is a noninvasive measure commonly used to assess autonomic nervous system activity. Standard short-term HRV analysis is typically based on 5-minute recordings, but shorter and longer analysis durations are also used in research and practice. This study will evaluate whether HRV values derived from 1-minute, 5-minute, 10-minute, and 20-minute analysis windows differ from one another and whether their relationships with systolic blood pressure, diastolic blood pressure, and mean arterial pressure change according to analysis duration. Participants will attend a single study visit. After a rest period, resting blood pressure and pulse will be measured, and a continuous HRV recording will be obtained using a chest strap device. The study is designed to provide methodological information on the comparability of different HRV analysis durations under the same physiological conditions.

Eligibility criteria

Qualifiers

Healthy adults aged 18 to 40 years

Willing and able to provide informed consent

Able to comply with pre-assessment instructions, including restrictions related to caffeine intake and strenuous physical activity

No condition preventing heart rate variability and blood pressure measurements

Disqualifiers

History of diagnosed cardiovascular, neurological, or autonomic nervous system disease

Known arrhythmia or pacemaker use

Regular use of medications that may affect heart rate variability, such as beta blockers or antiarrhythmic drugs

Acute infection, fever, or any condition affecting general health status on the day of assessment

Trial design

Treatments tested in this trial

  • Heart Rate Variability and Blood Pressure Assessment

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators